Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole
Pramipexole Special Survey on Long-Term Use
Sponsor: Boehringer Ingelheim
Listed as NCT00615914, this observational or N/A phase trial focuses on Parkinson Disease and remains completed. Sponsored by Boehringer Ingelheim, it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Feb 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Agano, Japan , Aizu-Wakamatsu, Japan , Akashi, Japan , Akita, Japan , Asahikawa, Japan , Asakura, Japan , Azumino, Japan , Bandō, Japan , Beppu, Japan , Bihoro, Japan and 262 more locations